New York State Common Retirement Fund’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,269
| Closed | -$138K | – | 3426 |
|
|
2024
Q1 | $138K | Buy |
3,269
+69
| +2% | +$2.91K | ﹤0.01% | 2613 |
|
|
2023
Q4 | $134K | Sell |
3,200
-85
| -3% | -$3.13K | ﹤0.01% | 2616 |
|
|
2023
Q3 | $124K | Sell |
3,285
-3,209
| -49% | -$120K | ﹤0.01% | 2625 |
|
|
2023
Q2 | $246K | Buy |
6,494
+3,058
| +89% | +$96K | ﹤0.01% | 2401 |
|
|
2023
Q1 | $83.6K | Hold |
3,436
| – | – | ﹤0.01% | 2860 |
|
|
2022
Q4 | $99.8K | Hold |
3,436
| – | – | ﹤0.01% | 2956 |
|
|
2022
Q3 | $103K | Hold |
3,436
| – | – | ﹤0.01% | 3006 |
|
|
2022
Q2 | $124K | Hold |
3,436
| – | – | ﹤0.01% | 2992 |
|
|
2022
Q1 | $149K | Hold |
3,436
| – | – | ﹤0.01% | 2920 |
|
|
2021
Q4 | $172K | Hold |
3,436
| – | – | ﹤0.01% | 2926 |
|
|
2021
Q3 | $219K | Hold |
3,436
| – | – | ﹤0.01% | 2875 |
|
|
2021
Q2 | $247K | Hold |
3,436
| – | – | ﹤0.01% | 2954 |
|
|
2021
Q1 | $253K | Hold |
3,436
| – | – | ﹤0.01% | 2736 |
|
|
2020
Q4 | $252K | Hold |
3,436
| – | – | ﹤0.01% | 2652 |
|
|
2020
Q3 | $188K | Hold |
3,436
| – | – | ﹤0.01% | 2680 |
|
|
2020
Q2 | $228K | Buy |
3,436
+1,805
| +111% | +$121K | ﹤0.01% | 2583 |
|
|
2020
Q1 | $100K | Hold |
1,631
| – | – | ﹤0.01% | 2768 |
|
|
2019
Q4 | $143K | Sell |
1,631
-1,149
| -41% | -$96.9K | ﹤0.01% | 2889 |
|
|
2019
Q3 | $210K | Hold |
2,780
| – | – | ﹤0.01% | 2748 |
|
|
2019
Q2 | $237K | Hold |
2,780
| – | – | ﹤0.01% | 2733 |
|
|
2019
Q1 | $300K | Buy |
2,780
+914
| +49% | +$91K | ﹤0.01% | 2544 |
|
|
2018
Q4 | $158K | Hold |
1,866
| – | – | ﹤0.01% | 2810 |
|
|
2018
Q3 | $183K | Hold |
1,866
| – | – | ﹤0.01% | 2867 |
|
|
2018
Q2 | $216K | Buy |
+1,866
| New | +$205K | ﹤0.01% | 2838 |
|
|
2017
Q1 | – | Sell |
-53,527
| Closed | -$5.63M | – | 3158 |
|
|
2016
Q4 | $5.63M | Sell |
53,527
-9,208
| -15% | -$965K | 0.01% | 1195 |
|
|
2016
Q3 | $6.93M | Buy |
62,735
+20,279
| +48% | +$2.69M | 0.01% | 1087 |
|
|
2016
Q2 | $6.18M | Hold |
42,456
| – | – | 0.01% | 1154 |
|
|
2016
Q1 | $6.08M | Buy |
42,456
+15,030
| +55% | +$2.13M | 0.01% | 1132 |
|
|
2015
Q4 | $4.24M | Hold |
27,426
| – | – | 0.01% | 1298 |
|
|
2015
Q3 | $3.92M | Hold |
27,426
| – | – | 0.01% | 1309 |
|
|
2015
Q2 | $3.94M | Sell |
27,426
-31,965
| -54% | -$4.56M | 0.01% | 1477 |
|
|
2015
Q1 | $8.38M | Buy |
59,391
+7,655
| +15% | +$1.18M | 0.01% | 965 |
|
|
2014
Q4 | $7.67M | Buy |
51,736
+31,118
| +151% | +$4.57M | 0.01% | 987 |
|
|
2014
Q3 | $3.17M | Buy |
20,618
+10,809
| +110% | +$1.63M | ﹤0.01% | 1410 |
|
|
2014
Q2 | $1.38M | Buy |
9,809
+5,346
| +120% | +$593K | ﹤0.01% | 1794 |
|
|
2014
Q1 | $495K | Hold |
4,463
| – | – | ﹤0.01% | 1924 |
|
|
2013
Q4 | $441K | Hold |
4,463
| – | – | ﹤0.01% | 1916 |
|
|
2013
Q3 | $339K | Hold |
4,463
| – | – | ﹤0.01% | 1891 |
|
|
2013
Q2 | $249K | Buy |
+4,463
| New | +$264K | ﹤0.01% | 1778 |
|
Other funds holding TARO
KAM
AIIMS
LI
GCM
LC
FFA
MPWT
New York State Common Retirement Fund's TARO Position: Q2 2024 in Review
New York State Common Retirement Fund sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 3,269 shares — an estimated $138K sold.
New York State Common Retirement Fund first reported a position in TARO in Q2 2013 and held it in 39 quarters. The position peaked at $8.38M in Q1 2015. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.
- New York State Common Retirement Fund reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
- New York State Common Retirement Fund sold 3,269 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $138K.
- New York State Common Retirement Fund first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 39 quarters.
- New York State Common Retirement Fund's Taro Pharmaceutical Industries Ltd. position peaked at $8.38M in Q1 2015.
- 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.
Based on New York State Common Retirement Fund's 13F filing for Q2 2024, filed 31 Jul 2024.